A Genetic Screen Identifies Hypothalamic Fgf15 as a Regulator of Glucagon Secretion.
A Genetic Screen Identifies Hypothalamic Fgf15 as a Regulator of Glucagon Secretion.
复制标题
DOI:
10.1016/j.celrep.2016.10.041
复制
发表时间:
2016-11-08
期刊:
影响因子:
8.8
通讯作者:
Thorens B
中科院分区:
文献类型:
--
作者:
Picard A;Soyer J;Berney X;Tarussio D;Quenneville S;Jan M;Grouzmann E;Burdet F;Ibberson M;Thorens B
The counterregulatory response to hypoglycemia, which restores normal blood glucose levels to ensure sufficient provision of glucose to the brain, is critical for survival. To discover underlying brain regulatory systems, we performed a genetic screen in recombinant inbred mice for quantitative trait loci (QTL) controlling glucagon secretion in response to neuroglucopenia. We identified a QTL on the distal part of chromosome 7 and combined this genetic information with transcriptomic analysis of hypothalami. This revealed Fgf15 as the strongest candidate to control the glucagon response. Fgf15 was expressed by neurons of the dorsomedial hypothalamus and the perifornical area. Intracerebroventricular injection of FGF19, the human ortholog of Fgf15, reduced activation by neuroglucopenia of dorsal vagal complex neurons, of the parasympathetic nerve, and lowered glucagon secretion. In contrast, silencing Fgf15 in the dorsomedial hypothalamus increased neuroglucopenia-induced glucagon secretion. These data identify hypothalamic Fgf15 as a regulator of glucagon secretion. Recombinant inbred mice screened for QTLs associated with glucagon secretion Combined QTL and transcriptomic analysis suggests a role for hypothalamic Fgf15 Fgf15 i.c.v. blunts neuroglucopenia-induced vagal nerve firing and glucagon secretion Silencing Fgf15 mRNA in the dorsomedial hypothalamus increases glucagon secretion Defects in the counterregulatory response to hypoglycemia and repeated hypoglycemic episodes are a major threat for insulin-treated diabetic patients. Picard et al. identify hypothalamic Fgf15 as a, so far, unsuspected regulator of glucagon secretion that acts as an inhibitor of vagal activity using a genetic screen and physiological studies.
登录
查看更多内容
影响因子:
7.7
作者:
McCrimmon, Rory J.;Shaw, Margaret;Sherwin, Robert S.
通讯作者:
Sherwin, Robert S.
影响因子:
7.7
作者:
O'Malley D;Reimann F;Simpson AK;Gribble FM
通讯作者:
Gribble FM
影响因子:
7.7
作者:
Levin, Barry E.;Becker, Thomas C.;Dunn-Meynell, Ambrose A.
通讯作者:
Dunn-Meynell, Ambrose A.
影响因子:
15.9
作者:
Morton, Gregory J.;Matsen, Miles E.;Schwartz, Michael W.
通讯作者:
Schwartz, Michael W.
DOI:
10.1152/ajpendo.00332.2001
发表时间:
2002-04-01
影响因子:
5.1
作者:
Burcelin, M;Crivelli, V;Thorens, B
通讯作者:
Thorens, B